ArticleBritish journal of pharmacology2018

The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis.

Barbara Schreier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.